Waters Corporation $WAT Shares Sold by Cambiar Investors LLC

Cambiar Investors LLC decreased its position in Waters Corporation (NYSE:WAT) by 6.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,761 shares of the medical instruments supplier’s stock after selling 1,646 shares during the quarter. Cambiar Investors LLC’s holdings in Waters were worth $8,294,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in WAT. Olde Wealth Management LLC acquired a new stake in Waters in the first quarter valued at approximately $25,000. Zions Bancorporation National Association UT purchased a new position in Waters in the first quarter valued at approximately $28,000. IFP Advisors Inc increased its stake in Waters by 118.9% in the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock valued at $30,000 after purchasing an additional 44 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in Waters in the first quarter valued at approximately $41,000. Finally, Creative Financial Designs Inc. ADV increased its stake in Waters by 533.3% in the second quarter. Creative Financial Designs Inc. ADV now owns 190 shares of the medical instruments supplier’s stock valued at $66,000 after purchasing an additional 160 shares during the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Performance

Shares of WAT opened at $350.17 on Friday. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. The firm has a market cap of $20.84 billion, a PE ratio of 31.58, a price-to-earnings-growth ratio of 3.19 and a beta of 1.04. The company’s 50 day simple moving average is $316.74 and its 200-day simple moving average is $324.55. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $423.56.

Waters (NYSE:WAT) last announced its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. The business had revenue of $608.55 million for the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%. As a group, equities analysts predict that Waters Corporation will post 12.86 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Jefferies Financial Group set a $385.00 price target on shares of Waters and gave the company a “buy” rating in a research note on Monday, August 4th. Redburn Partners set a $390.00 price target on shares of Waters in a research note on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft set a $315.00 price target on shares of Waters and gave the company a “hold” rating in a research note on Tuesday, August 5th. Rothschild Redb upgraded shares of Waters to a “strong-buy” rating in a research note on Wednesday, October 8th. Finally, UBS Group restated a “neutral” rating on shares of Waters in a research report on Tuesday, July 15th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $376.80.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.